PROLONGED RELEASE PREGABALIN (MisabriĀ®)
Clinical Indication
Comments
Not to be used across LLR.
Date of classification
February 2025
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.